Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples